FN2 Earnings Intelligence
Johnson & Johnson ratios (quarterly)
Johnson & Johnson (JNJ) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 | 6/28/2026 | 9/28/2026 est. | 12/28/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $38,474 | $18,577 | $18,231 | $21,688 | $20,422 | - | - |
| + Debt | $52,252 | $50,761 | $45,795 | $54,987 | $49,036 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $21,893 | $23,743 | $23,993 | $24,062 | $25,310 | $25,321.7 | $26,494.6 |
| % Growth | - | - | - | - | - | 5.5% | - |
| Gross Profit | $14,536 | $16,115 | $16,690 | $15,956 | $17,259 | - | - |
| % Margin | 66.4% | 67.9% | 69.6% | 66.3% | 68.2% | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $10,999 | $5,537 | $5,152 | $5,235 | $5,534 | - | - |
| % Margin | 50.2% | 23.3% | 21.5% | 21.8% | 21.9% | - | - |
| Diluted EPS | $4.54 | $2.29 | $2.12 | $2.14 | $2.27 | $3.05 | $3.03 |
| % Growth | - | - | - | - | - | 43.8% | - |
| Operating Cash Flow | $4,174 | - | - | $2,514 | - | - | - |
| CapEx | $795 | - | - | $1,049 | - | - | - |
| Free Cash Flow | $3,379 | - | - | $1,465 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 | 6/28/2026 | 9/28/2026 est. | 12/28/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $21,893 | $23,743 | $23,993 | $24,062 | $25,310 | $25,321.7 | $26,494.6 |
| Gross Profit | $14,536 | $16,115 | $16,690 | $15,956 | $17,259 | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $10,999 | $5,537 | $5,152 | $5,235 | $5,534 | - | - |
| Diluted EPS | $4.54 | $2.29 | $2.12 | $2.14 | $2.27 | $3.05 | $3.03 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 | 6/28/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $38,474 | $18,577 | $18,231 | $21,688 | $20,422 |
| Short-term Debt | $13,897 | $11,526 | $6,387 | $17,460 | $11,692 |
| Long-term Debt | $38,355 | $39,235 | $39,408 | $37,527 | $37,344 |
| Total Debt | $52,252 | $50,761 | $45,795 | $54,987 | $49,036 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 | 6/28/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $4,174 | - | - | $2,514 | - |
| Capital Expenditure | $795 | - | - | $1,049 | - |
| Free Cash Flow | $3,379 | - | - | $1,465 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 | 6/28/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 66.4% | 67.9% | 69.6% | 66.3% | 68.2% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 50.2% | 23.3% | 21.5% | 21.8% | 21.9% |
| FCF Margin | 15.4% | - | - | 6.1% | - |
| Diluted EPS Growth | - | - | - | - | - |